Southern Shuanglin to lift trading restrictions on 991,607 shares

Southern Shuanglin Bio-Pharmacy (SZSE:000403) announced that trading restrictions will be lifted on 991,607 shares, effective June 25, 2025. The affected shares account for 0.1043% of the company's total share capital. The shares are held by three shareholders: Wang Qingping, Yang Zhou and Zhangshu City State-owned Assets Operation Co., Ltd. The lifting of restrictions complies with previous equity division reform commitments. The original equity division reform involved transferring CNY6,089.4108 from the company's capital reserve to the tradable shareholders by allotting 6 shares for every 10 shares held. Post release, restricted shares will constitute 1.02% of the total share capital, while unrestricted will rise to 98.98%. The company confirms there are no instances of non-operating fund occupation or irregular guarantees related to the released shares.